Current european regulatory perspectives on insulin analogues

Current european regulatory perspectives on insulin analogues

<p>Abstract</p> <p>Insulin analogues are increasingly considered as an alternative to human insulin in the therapy of diabetes mellitus. Insulin analogues (IAs) are chemically different from human insulin and may have different pharmacokinetic or pharmacodynamic properties. The sig...

Full description

Bibliographic Details
Main Authors: Enzmann Harald G, Weise Martina
Format: Article
Language:English
Published: BMC 2011-07-01
Series:Diabetology & Metabolic Syndrome
Subjects:
Insulin analogues
cancer
marketing authorization
guideline
European Medicines Agency
health technology assessment
Online Access:http://www.dmsjournal.com/content/3/1/14

Internet

http://www.dmsjournal.com/content/3/1/14

Similar Items